Tijana Bugarcic has a PhD in drug discovery and an MBA in strategy. She provides consultancy and coaching services to biotechs, big pharma and medical device companies. She acts as an Advisor for the European Commission and the European Bank and as an External Consultant for the European Centre for Diseases Prevention and Control (ECDC). In addition she evaluates investment projects for the European Commission, including those investments in new therapies for rare diseases. In addition she runs collaborative workshops and an online portal for collaboration across the rare diseases and pediatric drugs discovery market.